Chandan Healthcare (NSE:CHANDAN) YoY EBITDA Growth: 0.00% (As of Dec. 2025)


NSE:CHANDAN Chandan Healthcare Ltd NSE:CHANDAN
17 GF Score
Price ₹220.85
! 4 Warning Signs
View Full Analysis

What is Chandan Healthcare YoY EBITDA Growth?

Chandan Healthcare NSE:CHANDAN +0.57% 17 YoY EBITDA Growth is 0.00% as of Dec. 2025. GuruFocus rates NSE:CHANDAN with a GF Score™ of 17/100. The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chandan Healthcare's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 0.00%.

Chandan Healthcare's EBITDA per Share for the three months ended in Dec. 2025 was ₹4.25.

Chandan Healthcare YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Chandan Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandan Healthcare YoY EBITDA Growth Chart

Chandan Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
0.00 256.26 207.14 86.30

Chandan Healthcare Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:CHANDAN
17GF Score
Chandan Healthcare Ltd NSE:CHANDAN
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandan Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chandan Healthcare's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(20.834-11.183)/ | 11.183 |
=86.30 %

Chandan Healthcare's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(4.254-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
Chandan Healthcare (NSE:CHANDAN) has a YoY EBITDA Growth of 0.00% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Chandan Healthcare and its competitors.
Is Chandan Healthcare's YoY EBITDA Growth too high?
Chandan Healthcare's current YoY EBITDA Growth is 0.00%. Overall, Chandan Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's YoY EBITDA Growth compare to TMO and DHR?
Chandan Healthcare's YoY EBITDA Growth of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Diagnostics & Research company?
A good YoY EBITDA Growth depends on the Medical Diagnostics & Research industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Chandan Healthcare and its competitors. Chandan Healthcare's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. Chandan Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current YoY EBITDA Growth is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chandan Healthcare Business Description

Address Kursi Road, Biotech Park, Sector G, Jankipuram, Lucknow, UP, IND, 226021
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score

Get the complete analysis for NSE:CHANDAN

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹220.85
Price